WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003055890) THIENOPYRIMIDINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/055890    International Application No.:    PCT/US2002/041168
Publication Date: 10.07.2003 International Filing Date: 20.12.2002
Chapter 2 Demand Filed:    21.07.2003    
IPC:
C07D 495/04 (2006.01)
Applicants: BAYER PHARMACEUTICALS CORPORATION [US/US]; 400 Morgan Lane, West Haven, CT 06516 (US) (For All Designated States Except US).
DUMAS, Jacques [FR/US]; (US) (For US Only).
SIBLEY, Robert [US/US]; (US) (For US Only).
WOOD, Jill [US/US]; (US) (For US Only)
Inventors: DUMAS, Jacques; (US).
SIBLEY, Robert; (US).
WOOD, Jill; (US)
Agent: GREENMAN, Jeffrey, M.; Bayer Pharmaceuticals Corporation, 400 Morgan Lane, West Haven, CT 06516 (US)
Priority Data:
60/343,048 21.12.2001 US
Title (EN) THIENOPYRIMIDINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS
(FR) COMPOSES DERIVES DE THIENOPYRIMIDINE UTILISES COMME INHIBITEURS DE LA PROLYLPEPTIDASE, INDUCTEURS D'APOPTOSE ET AGENTS DE TRAITEMENT ANTICANCEREUX
Abstract: front page image
(EN)The compounds of the invention are thienopyrimidine derivatives of the formula (I):wherein X is OR3 or NR3R4; q, R1, R2, R3, and R4 are described in the specification. These compounds are useful for the inhibiting the prolylpeptidase, inducing apoptosis and treating cancer.
(FR)Les composés de l'invention sont des dérivés de thiénopyrimidine représentés par la formule (I) dans laquelle X est OR3 ou NR3R4; et q, R1, R2, R3, et R4 sont comme spécifiés dans le descriptif. Ces composés conviennent bien comme inhibiteurs de la prolylpeptidase, inducteurs d'apoptose et agents anti-cancéreux.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)